The growing awareness about the advantages of advanced testing procedures is projected to further stimulate the market growth in the estimated timeframe.
Moreover, the rising corrections and improvements in the reimbursement scenario in prenatal testing are further predicted to bolster the market growth in the estimated years.
Additionally, the augmenting incidences of miscarriages globally are also adding traction to market growth.To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/prenatal-testing-marketMajor players in the global market include Quest Diagnostics, Natera, Inc., GeneDx, Inc., Illumina, Inc., Prenatal Paternities Inc., Ravgen Inc., Ariosa Diagnostics, Inc., Counsyl, Inc., LabCorp, and Eurofins NTD Inc., among others.Prenatal Testing Market Solution Insight:The ultrasound sub-segment is projected to expand significantly over the projected timespan, registering a CAGR of 13.2%.
The growth of the segment can be accredited to the secure and pain-free attributes of ultrasound prenatal testing procedures.
The method utilizes sound waves to produce images that provide insights into the baby’s position and condition.The Prenatal Testing Market is expected to be valued at USD 8.08 Billion by 2027 from USD 3.23 Billion in 2019, registering a CAGR of 12.9% through the forecast period.Method Outlook (Revenue, USD Billion; 2017-2027)Blood or SalivaUltrasoundUrineAmniocentesisPercutaneous umbilical blood samplingChorionic villus samplingTest Type Outlook (Revenue, USD Billion; 2017-2027)Non-InvasiveInvasiveRegional Analysis of the Prenatal Testing Market Includes:North America (U.S., Canada)Europe (U.K., Italy, Germany, France, Rest of EU)Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)Latin America (Chile, Brazil, Argentina, Rest of Latin America)Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)Thank you for reading our report.
To request a customization or for further inquiries, kindly get in touch with us.
The growing awareness about the advantages of advanced testing procedures is projected to further stimulate the market growth in the estimated timeframe.
Moreover, the rising corrections and improvements in the reimbursement scenario in prenatal testing are further predicted to bolster the market growth in the estimated years.
Additionally, the augmenting incidences of miscarriages globally are also adding traction to market growth.To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/prenatal-testing-marketMajor players in the global market include Quest Diagnostics, Natera, Inc., GeneDx, Inc., Illumina, Inc., Prenatal Paternities Inc., Ravgen Inc., Ariosa Diagnostics, Inc., Counsyl, Inc., LabCorp, and Eurofins NTD Inc., among others.Prenatal Testing Market Solution Insight:The ultrasound sub-segment is projected to expand significantly over the projected timespan, registering a CAGR of 13.2%.
The growth of the segment can be accredited to the secure and pain-free attributes of ultrasound prenatal testing procedures.
The method utilizes sound waves to produce images that provide insights into the baby’s position and condition.The Prenatal Testing Market is expected to be valued at USD 8.08 Billion by 2027 from USD 3.23 Billion in 2019, registering a CAGR of 12.9% through the forecast period.Method Outlook (Revenue, USD Billion; 2017-2027)Blood or SalivaUltrasoundUrineAmniocentesisPercutaneous umbilical blood samplingChorionic villus samplingTest Type Outlook (Revenue, USD Billion; 2017-2027)Non-InvasiveInvasiveRegional Analysis of the Prenatal Testing Market Includes:North America (U.S., Canada)Europe (U.K., Italy, Germany, France, Rest of EU)Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)Latin America (Chile, Brazil, Argentina, Rest of Latin America)Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)Thank you for reading our report.
To request a customization or for further inquiries, kindly get in touch with us.